Amanote Research

Amanote Research

    RegisterSign In

The Use of Angiotensin Converting Enzyme Inhibitors During the First Trimester of Pregnancy

Journal of Pharmacovigilance
doi 10.4172/2329-6887.1000129
Full Text
Open PDF
Abstract

Available in full text

Date

January 1, 2016

Authors
Lyn ColvinBarry NJ Walters
Publisher

OMICS Publishing Group


Related search

Chronic Hypertension During the First Trimester of Pregnancy: What Is New About the Use of Angiotensin-Converting Enzyme Inhibitors?

World Journal of Gynecology & Womens Health
2019English

Dosage of Angiotensin Converting Enzyme Inhibitors

BMJ
1995English

Angiotensin Converting Enzyme (ACE) Inhibitors

Annual Review of Pharmacology and Toxicology
ToxicologyPharmacology
1982English

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

Angiotensin-Converting Enzyme Inhibitors and Angioedema: Estimating the Risk

Hypertension
Internal Medicine
2008English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

N-Protected Tripeptide Inhibitors of Angiotensin Converting Enzyme.

Agricultural and Biological Chemistry
1990English

Angiotensin Converting Enzyme Inhibitors for Cancer Treatment?

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2004English

Angiotensin Converting Enzyme Inhibitors and Diabetic Nephropathy.

BMJ
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy